Stonepeak and Spirit Super Complete Acquisition of Australia’s GeelongPort
NEW YORK & SYDNEY & MELBOURNE, Australia--(BUSINESS WIRE)--Stonepeak, a leading alternative investment firm specializing in…
3 years ago
Wire Stories
FPT Software Named a Major Player in IDC MarketScape: Asia/Pacific Manufacturing Execution Systems 2023 Vendor Assessment
HANOI, Vietnam--(BUSINESS WIRE)--#FPT--FPT Software has been named as a Major Player in the IDC MarketScape:…
3 years ago
Geekbar Warns Against the Fake Disposable Vape Brand
SHENZHEN, China--(BUSINESS WIRE)--Geekbar has always been liked by e-cigarette consumers around the world with its…
3 years ago
AntChain Unveils Multiple New Web3 Initiatives With Partners
HANGZHOU, China--(BUSINESS WIRE)--Together with its partners, AntChain today unveiled a series of new Web3 initiatives,…
3 years ago
Worldpay From FIS Opens New Growth Opportunities with United Arab Emirates Expansion
Key facts Worldpay from FIS continues to drive global e-commerce with new domestic acquiring capability…
3 years ago
Pony.ai is First to Receive Permit to Provide Public-Facing, Fully Driverless Robotaxi Service in Guangzhou
Pony.ai also operates public-facing, fully driverless robotaxis in Beijing and is the only company to…
3 years ago
Parade Technologies Reports First Quarter 2023 Financial Results
Financial Highlights: Q123 consolidated revenue US$99.99 million, compared with US$210.72 million in the year-ago quarter…
3 years ago
Tide Launches UK-India Exchange Programme to Boost Global Exports & Entrepreneurship
LONDON--(BUSINESS WIRE)--Tide, the UK's leading SME-focused business financial platform, today announced the launch of the…
3 years ago
Elevating Social Gaming with Voice Chat: Tamatem Teams Up with ZEGOCLOUD to Transform Connections in the Arab World
SINGAPORE--(BUSINESS WIRE)--#appdev--Tamatem Inc., the premier mobile games publisher in the Arabic-speaking market, has launched Wanas,…
3 years ago
Alentis Therapeutics Reports Positive Topline Results From Phase 1 Multiple-ascending Dose Cohorts Study
The trial confirms ALE.F02’s good safety profile, exposure and target biological activity BASEL, Switzerland--(BUSINESS WIRE)--Alentis…
3 years ago